IBDEI207 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,31975,2)
;;=^338265
;;^UTILITY(U,$J,358.3,31976,0)
;;=N85.00^^126^1638^12
;;^UTILITY(U,$J,358.3,31976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31976,1,3,0)
;;=3^Endometrial Hyperplasia,Unspec
;;^UTILITY(U,$J,358.3,31976,1,4,0)
;;=4^N85.00
;;^UTILITY(U,$J,358.3,31976,2)
;;=^331542
;;^UTILITY(U,$J,358.3,31977,0)
;;=N85.2^^126^1638^13
;;^UTILITY(U,$J,358.3,31977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31977,1,3,0)
;;=3^Enlarged Uterus
;;^UTILITY(U,$J,358.3,31977,1,4,0)
;;=4^N85.2
;;^UTILITY(U,$J,358.3,31977,2)
;;=^270521
;;^UTILITY(U,$J,358.3,31978,0)
;;=D25.9^^126^1638^14
;;^UTILITY(U,$J,358.3,31978,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31978,1,3,0)
;;=3^Fibroid Uterus
;;^UTILITY(U,$J,358.3,31978,1,4,0)
;;=4^D25.9
;;^UTILITY(U,$J,358.3,31978,2)
;;=^5002081
;;^UTILITY(U,$J,358.3,31979,0)
;;=Z85.42^^126^1638^15
;;^UTILITY(U,$J,358.3,31979,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31979,1,3,0)
;;=3^Hx of Uterine Cancer
;;^UTILITY(U,$J,358.3,31979,1,4,0)
;;=4^Z85.42
;;^UTILITY(U,$J,358.3,31979,2)
;;=^5063419
;;^UTILITY(U,$J,358.3,31980,0)
;;=N81.2^^126^1638^16
;;^UTILITY(U,$J,358.3,31980,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31980,1,3,0)
;;=3^Incomplete Uterovaginal Prolapse
;;^UTILITY(U,$J,358.3,31980,1,4,0)
;;=4^N81.2
;;^UTILITY(U,$J,358.3,31980,2)
;;=^5015839
;;^UTILITY(U,$J,358.3,31981,0)
;;=N85.01^^126^1638^11
;;^UTILITY(U,$J,358.3,31981,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31981,1,3,0)
;;=3^Endomet Hyperpla w/o Atyp
;;^UTILITY(U,$J,358.3,31981,1,4,0)
;;=4^N85.01
;;^UTILITY(U,$J,358.3,31981,2)
;;=^338264
;;^UTILITY(U,$J,358.3,31982,0)
;;=D25.0^^126^1638^17
;;^UTILITY(U,$J,358.3,31982,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31982,1,3,0)
;;=3^Submucous Fibroid
;;^UTILITY(U,$J,358.3,31982,1,4,0)
;;=4^D25.0
;;^UTILITY(U,$J,358.3,31982,2)
;;=^267640
;;^UTILITY(U,$J,358.3,31983,0)
;;=N93.9^^126^1638^18
;;^UTILITY(U,$J,358.3,31983,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31983,1,3,0)
;;=3^Uterine Bleeding
;;^UTILITY(U,$J,358.3,31983,1,4,0)
;;=4^N93.9
;;^UTILITY(U,$J,358.3,31983,2)
;;=^5015916
;;^UTILITY(U,$J,358.3,31984,0)
;;=N85.4^^126^1638^19
;;^UTILITY(U,$J,358.3,31984,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31984,1,3,0)
;;=3^Uterine Malposition
;;^UTILITY(U,$J,358.3,31984,1,4,0)
;;=4^N85.4
;;^UTILITY(U,$J,358.3,31984,2)
;;=^270525
;;^UTILITY(U,$J,358.3,31985,0)
;;=N84.0^^126^1638^20
;;^UTILITY(U,$J,358.3,31985,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31985,1,3,0)
;;=3^Uterine Polyps
;;^UTILITY(U,$J,358.3,31985,1,4,0)
;;=4^N84.0
;;^UTILITY(U,$J,358.3,31985,2)
;;=^270517
;;^UTILITY(U,$J,358.3,31986,0)
;;=N81.4^^126^1638^21
;;^UTILITY(U,$J,358.3,31986,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31986,1,3,0)
;;=3^Uterovaginal Prolapse,Unspec
;;^UTILITY(U,$J,358.3,31986,1,4,0)
;;=4^N81.4
;;^UTILITY(U,$J,358.3,31986,2)
;;=^5015841
;;^UTILITY(U,$J,358.3,31987,0)
;;=O02.0^^126^1639^3
;;^UTILITY(U,$J,358.3,31987,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31987,1,3,0)
;;=3^Blighted Ovum
;;^UTILITY(U,$J,358.3,31987,1,4,0)
;;=4^O02.0
;;^UTILITY(U,$J,358.3,31987,2)
;;=^5015978
;;^UTILITY(U,$J,358.3,31988,0)
;;=O03.9^^126^1639^4
;;^UTILITY(U,$J,358.3,31988,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31988,1,3,0)
;;=3^Complete SAB
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI207 3747 printed Sep 23, 2025@19:55:14 Page 2
IBDEI207 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,31975,2)
+2 ;;=^338265
+3 ;;^UTILITY(U,$J,358.3,31976,0)
+4 ;;=N85.00^^126^1638^12
+5 ;;^UTILITY(U,$J,358.3,31976,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,31976,1,3,0)
+8 ;;=3^Endometrial Hyperplasia,Unspec
+9 ;;^UTILITY(U,$J,358.3,31976,1,4,0)
+10 ;;=4^N85.00
+11 ;;^UTILITY(U,$J,358.3,31976,2)
+12 ;;=^331542
+13 ;;^UTILITY(U,$J,358.3,31977,0)
+14 ;;=N85.2^^126^1638^13
+15 ;;^UTILITY(U,$J,358.3,31977,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,31977,1,3,0)
+18 ;;=3^Enlarged Uterus
+19 ;;^UTILITY(U,$J,358.3,31977,1,4,0)
+20 ;;=4^N85.2
+21 ;;^UTILITY(U,$J,358.3,31977,2)
+22 ;;=^270521
+23 ;;^UTILITY(U,$J,358.3,31978,0)
+24 ;;=D25.9^^126^1638^14
+25 ;;^UTILITY(U,$J,358.3,31978,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,31978,1,3,0)
+28 ;;=3^Fibroid Uterus
+29 ;;^UTILITY(U,$J,358.3,31978,1,4,0)
+30 ;;=4^D25.9
+31 ;;^UTILITY(U,$J,358.3,31978,2)
+32 ;;=^5002081
+33 ;;^UTILITY(U,$J,358.3,31979,0)
+34 ;;=Z85.42^^126^1638^15
+35 ;;^UTILITY(U,$J,358.3,31979,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,31979,1,3,0)
+38 ;;=3^Hx of Uterine Cancer
+39 ;;^UTILITY(U,$J,358.3,31979,1,4,0)
+40 ;;=4^Z85.42
+41 ;;^UTILITY(U,$J,358.3,31979,2)
+42 ;;=^5063419
+43 ;;^UTILITY(U,$J,358.3,31980,0)
+44 ;;=N81.2^^126^1638^16
+45 ;;^UTILITY(U,$J,358.3,31980,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,31980,1,3,0)
+48 ;;=3^Incomplete Uterovaginal Prolapse
+49 ;;^UTILITY(U,$J,358.3,31980,1,4,0)
+50 ;;=4^N81.2
+51 ;;^UTILITY(U,$J,358.3,31980,2)
+52 ;;=^5015839
+53 ;;^UTILITY(U,$J,358.3,31981,0)
+54 ;;=N85.01^^126^1638^11
+55 ;;^UTILITY(U,$J,358.3,31981,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,31981,1,3,0)
+58 ;;=3^Endomet Hyperpla w/o Atyp
+59 ;;^UTILITY(U,$J,358.3,31981,1,4,0)
+60 ;;=4^N85.01
+61 ;;^UTILITY(U,$J,358.3,31981,2)
+62 ;;=^338264
+63 ;;^UTILITY(U,$J,358.3,31982,0)
+64 ;;=D25.0^^126^1638^17
+65 ;;^UTILITY(U,$J,358.3,31982,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,31982,1,3,0)
+68 ;;=3^Submucous Fibroid
+69 ;;^UTILITY(U,$J,358.3,31982,1,4,0)
+70 ;;=4^D25.0
+71 ;;^UTILITY(U,$J,358.3,31982,2)
+72 ;;=^267640
+73 ;;^UTILITY(U,$J,358.3,31983,0)
+74 ;;=N93.9^^126^1638^18
+75 ;;^UTILITY(U,$J,358.3,31983,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,31983,1,3,0)
+78 ;;=3^Uterine Bleeding
+79 ;;^UTILITY(U,$J,358.3,31983,1,4,0)
+80 ;;=4^N93.9
+81 ;;^UTILITY(U,$J,358.3,31983,2)
+82 ;;=^5015916
+83 ;;^UTILITY(U,$J,358.3,31984,0)
+84 ;;=N85.4^^126^1638^19
+85 ;;^UTILITY(U,$J,358.3,31984,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,31984,1,3,0)
+88 ;;=3^Uterine Malposition
+89 ;;^UTILITY(U,$J,358.3,31984,1,4,0)
+90 ;;=4^N85.4
+91 ;;^UTILITY(U,$J,358.3,31984,2)
+92 ;;=^270525
+93 ;;^UTILITY(U,$J,358.3,31985,0)
+94 ;;=N84.0^^126^1638^20
+95 ;;^UTILITY(U,$J,358.3,31985,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,31985,1,3,0)
+98 ;;=3^Uterine Polyps
+99 ;;^UTILITY(U,$J,358.3,31985,1,4,0)
+100 ;;=4^N84.0
+101 ;;^UTILITY(U,$J,358.3,31985,2)
+102 ;;=^270517
+103 ;;^UTILITY(U,$J,358.3,31986,0)
+104 ;;=N81.4^^126^1638^21
+105 ;;^UTILITY(U,$J,358.3,31986,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,31986,1,3,0)
+108 ;;=3^Uterovaginal Prolapse,Unspec
+109 ;;^UTILITY(U,$J,358.3,31986,1,4,0)
+110 ;;=4^N81.4
+111 ;;^UTILITY(U,$J,358.3,31986,2)
+112 ;;=^5015841
+113 ;;^UTILITY(U,$J,358.3,31987,0)
+114 ;;=O02.0^^126^1639^3
+115 ;;^UTILITY(U,$J,358.3,31987,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,31987,1,3,0)
+118 ;;=3^Blighted Ovum
+119 ;;^UTILITY(U,$J,358.3,31987,1,4,0)
+120 ;;=4^O02.0
+121 ;;^UTILITY(U,$J,358.3,31987,2)
+122 ;;=^5015978
+123 ;;^UTILITY(U,$J,358.3,31988,0)
+124 ;;=O03.9^^126^1639^4
+125 ;;^UTILITY(U,$J,358.3,31988,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,31988,1,3,0)
+128 ;;=3^Complete SAB
